RBC Capital analyst Gregory Renza maintained a Buy rating on Nuvation Bio (NUVB – Research Report) today and set a price target of $6.00.

Gerard Cassidy, RBC Capital Markets large cap bank analyst, joins 'Squawk Box' to discuss Donald Trump's victory in the 2024 ...

Fintel reports that on November 5, 2024, RBC Capital downgraded their outlook for Verrica Pharmaceuticals (NasdaqGM:VRCA) ...

RBC Capital analyst Gregory Renza maintained a Buy rating on Verastem (VSTM – Research Report) today and set a price target of $13.00.

Former RBC advisor claims firm discriminated against her, and the timing of her firing could let the firm take a large portion of her book without compensation.

A big part of the trouble with the RBC rule is that Ginnie Mae is essentially using its limited legal authority to qualify ...

RBC Capital lowered the firm’s price target on Aptiv (APTV) to $72 from $82 and keeps an Outperform rating on the shares after its Q3 results and guidance cut. The company’s macro headwinds ...

ConocoPhillips is exploring a sale of some of its shale operations in the Permian Basin worth more than $1 billion, two years ...

Fidelity National Information Services beats Q3 estimates, and raises full-year outlook Analysts maintain rating.

RBC Capital lowered the firm’s price target on Magna (MGA) to $42 from $47 and keeps a Sector Perform rating on the shares as ...

CNW/ - RBC has launched a new approach to community investment aimed at helping to address some of society's most pressing challenges. RBC, RBC Foundation ...

Investing.com -- Shares of Burberry (LON: BRBY) saw a rise on Wednesday following an upgrade by RBC Capital Markets to an "outperform" rating from a "sector perform” rating, accompanied by a price ...